Major facilitator superfamily MfsA contributes to multidrug resistance in emerging nosocomial pathogen Stenotrophomonas maltophilia. Dulyayangkul P, Charoenlap N, Srijaruskul K, Mongkolsuk S, Vattanaviboon P. J Antimicrob Chemother. 2016 Oct;71(10):2990-1. doi: 10.1093/jac/dkw233. No abstract

28 Dec 2016
0

Major facilitator superfamily MfsA contributes to multidrug resistance in emerging nosocomial pathogen Stenotrophomonas maltophilia.
Dulyayangkul P, Charoenlap N, Srijaruskul K, Mongkolsuk S, Vattanaviboon P.
J Antimicrob Chemother. 2016 Oct;71(10):2990-1. doi: 10.1093/jac/dkw233. No abstract

Tags

Share this

Related Posts

Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma. Chaiyawat P, Klangjorhor J, Settakorn J, Champattanachai V, Phanphaisarn A, Teeyakasem P, Svasti J, Pruksakorn D*. Transl Oncol 2017;10(5):846-53.

Recent Posts